This announcement is a separate document:
天津發展：天津力生製藥股份有限公司截至二零二二年十二月三十一日止年度之經審核財務業績
TIANJIN DEV: Audited Financial Results for the year ended 31 December 2022 of Tianjin Lisheng Pharmaceutical Co., Ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.